UBS Group’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01K | Sell |
548
-284
| -34% | -$522 | ﹤0.01% | 8361 |
|
|
2025
Q1 | $2.22K | Sell |
832
-292
| -26% | -$779 | ﹤0.01% | 8059 |
|
|
2024
Q4 | $4.96K | Sell |
1,124
-4,451
| -80% | -$19.6K | ﹤0.01% | 7468 |
|
|
2024
Q3 | $87.8K | Buy |
+5,575
| New | +$87.8K | ﹤0.01% | 5262 |
|
|
2024
Q2 | – | Sell |
-49
| Closed | -$1.78K | – | 8443 |
|
|
2024
Q1 | $1.78K | Buy |
+49
| New | +$1.78K | ﹤0.01% | 6878 |
|
|
2023
Q4 | – | Sell |
-7
| Closed | -$229 | – | 8199 |
|
|
2023
Q3 | $229 | Buy |
+7
| New | +$229 | ﹤0.01% | 7529 |
|
|
2023
Q2 | – | Sell |
-258
| Closed | -$13.1K | – | 7964 |
|
|
2023
Q1 | $13.1K | Buy |
+258
| New | +$13.1K | ﹤0.01% | 6321 |
|
|
2022
Q4 | – | Sell |
-39
| Closed | -$3K | – | 9573 |
|
|
2022
Q3 | $3K | Sell |
39
-23
| -37% | -$1.77K | ﹤0.01% | 8422 |
|
|
2022
Q2 | $10K | Buy |
62
+17
| +38% | +$2.74K | ﹤0.01% | 6916 |
|
|
2022
Q1 | $28K | Sell |
45
-10
| -18% | -$6.22K | ﹤0.01% | 6031 |
|
|
2021
Q4 | $68K | Buy |
55
+30
| +120% | +$37.1K | ﹤0.01% | 5557 |
|
|
2021
Q3 | $71K | Buy |
+25
| New | +$71K | ﹤0.01% | 4991 |
|
|
2021
Q2 | – | Sell |
-2
| Closed | -$2K | – | 8335 |
|
|
2021
Q1 | $2K | Hold |
2
| – | – | ﹤0.01% | 7567 |
|
|
2020
Q4 | $3K | Buy |
+2
| New | +$3K | ﹤0.01% | 6960 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | -$1K | – | 7154 |
|
|
2020
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 6892 |
|
|
2020
Q1 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 6829 |
|
|
2019
Q4 | – | Sell |
-3
| Closed | -$5K | – | 7047 |
|
|
2019
Q3 | $5K | Sell |
3
-2
| -40% | -$3.33K | ﹤0.01% | 6494 |
|
|
2019
Q2 | $12K | Sell |
5
-6
| -55% | -$14.4K | ﹤0.01% | 6063 |
|
|
2019
Q1 | $27K | Buy |
11
+6
| +120% | +$14.7K | ﹤0.01% | 5212 |
|
|
2018
Q4 | $6K | Sell |
5
-4
| -44% | -$4.8K | ﹤0.01% | 6544 |
|
|
2018
Q3 | $24K | Hold |
9
| – | – | ﹤0.01% | 5780 |
|
|
2018
Q2 | $24K | Buy |
9
+4
| +80% | +$10.7K | ﹤0.01% | 5650 |
|
|
2018
Q1 | $22K | Sell |
5
-8
| -62% | -$35.2K | ﹤0.01% | 5477 |
|
|
2017
Q4 | $32K | Buy |
13
+5
| +63% | +$12.3K | ﹤0.01% | 5222 |
|
|
2017
Q3 | $29K | Sell |
8
-6
| -43% | -$21.8K | ﹤0.01% | 5281 |
|
|
2017
Q2 | $57K | Buy |
14
+13
| +1,300% | +$52.9K | ﹤0.01% | 4644 |
|
|
2017
Q1 | $3K | Hold |
1
| – | – | ﹤0.01% | 6235 |
|
|
2016
Q4 | $3K | Hold |
1
| – | – | ﹤0.01% | 6419 |
|
|
2016
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 6455 |
|
|
2016
Q2 | $3K | Hold |
1
| – | – | ﹤0.01% | 6408 |
|
|
2016
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 6421 |
|
|
2015
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 6579 |
|
|
2015
Q3 | $10K | Hold |
1
| – | – | ﹤0.01% | 5921 |
|
|
2015
Q2 | $7K | Hold |
1
| – | – | ﹤0.01% | 6141 |
|
|
2015
Q1 | $12K | Hold |
1
| – | – | ﹤0.01% | 5741 |
|
|
2014
Q4 | $13K | Buy |
+1
| New | +$13K | ﹤0.01% | 5850 |
|